1. Postoperative tumor treatment strategies: From basic research to clinical therapy
    Minna Xiao et al, 2024, VIEW CrossRef
  2. The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
    Fatimat Kipkeeva et al, 2022, International Journal of Molecular Sciences CrossRef
  3. Galectin-9 in Gastroenterological Cancer
    Asahiro Morishita et al, 2023, International Journal of Molecular Sciences CrossRef
  4. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
    Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  5. Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival
    Victoriano Mendieta-Carmona et al, 2023, OncoTargets and Therapy CrossRef
  6. The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
    Xi-Yang Tang et al, 2022, Cancers CrossRef
  7. Systematic analyzing a five- miRNA panel and its diagnostic value of plasma expression in colorectal cancer
    Si-Qi Li et al, 2023, Molecular Biology Reports CrossRef
  8. ATXN3 functions as a tumor suppressor through potentiating galectin-9-mediated apoptosis in human colon adenocarcinoma
    Yang Cheng et al, 2024, Journal of Biological Chemistry CrossRef
  9. Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism
    Anthony Lefebvre et al, 2023, Journal of Extracellular Vesicles CrossRef
  10. Galectin-9 and PD-L1 Antibody Blockade Combination Therapy Inhibits Tumour Progression in Pancreatic Cancer
    Enliang Li et al, 2023, Immunotherapy CrossRef
  11. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients
    Ella G. Markalunas et al, 2024, Genes CrossRef
  12. Enzyme Prodrug Therapy with Photo-Cross-Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles
    Shambojit Roy et al, 2022, ACS Nano CrossRef
  13. Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity
    Natasha Ustyanovska Avtenyuk et al, 2021, Biomedicines CrossRef
  14. A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice
    Alexandre Quilbe et al, 2023, Frontiers in Immunology CrossRef
  15. Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?
    Christian Bailly et al, 2021, Cancers CrossRef
  16. Lectins in Health and Diseases: Galectins and Cancer
    Shirsha Nandi et al, 2021, Lectins CrossRef
  17. Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small‐cell lung cancer and enhance the efficacy of platinum‐based chemotherapy
    Anqi Lin et al, 2023, Cancer Innovation CrossRef